By AdjAssocProf Craig Haifer

Conference Abstracts

Su WK; Wilson W; Pipicella J; Haifer C; Williams A-J; Lynch K; Forbes A; Walker G; Schultz M; Lawrance I; An Y-K; Brett L; Connor SJ; Andrews J, 2024, 'The real-world use of five aminosalicylate treatment for ulcerative colitis: Crohn's Colitis Cure (CCC) data insights program', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 39, pp. 181 - 182

Cameron K; Sam M; Thennakoon N; Gu B; Arzivian A; Skinner T; Shelton E; Haifer C; Connor SJ; Toong C; Gibson P; Gibson D; Boussioutas A; Sparrow MP; Ward M, 2024, 'The role of bound anti-drug antibodies to infliximab in predicting future immunogenic failure when de-escalating from combination therapy with an immunomodulator to anti-TNF monotherapy: The Risk Assessment of drug-bound anti-drug-antibodies for Predicting immunogenicity during Immunomodulator De-escalation to Infliximab Monotherapy (RAPIDIM) Study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 39, pp. 211 - 212

Suo P; Thin L; Srinivasan A; Winston J; Jeffrey A; Menon S; Ghaly S; Haifer C, 2023, 'Comparing long-term outcomes in inflammatory bowel disease patients between switch and non-switch cohorts: no differences in infliximab persistence or safety outcomes after 54 months', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 17, pp. 884 - 884, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000960367601460&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pudipeddi A; Paramsothy S; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An YK; Begun J; Connor S; Corte C; Ward M; De Cruz P; Fung C; Redmond D; Leong RW, 2023, 'Withdrawal versus continuation of thiopurine in vedolizumab-treated patients with Ulcerative Colitis (VIEWS): a multi-centre randomised controlled trial', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 17, pp. 542 - 542, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000960367601125&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Leong R; Haifer C; Kaakoush N; Chetwood J; Pudipeddi A; Paramsothy S, 2022, 'Baseline endoscopic activity and concomitant medications in the prediction of oral fecal microbiota therapeutic efficacy in mild-moderate ulcerative colitis: Lyophilised Oral Faecal Microbiota Transplantation for Ulcerative Colitis (LOTUS) study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 37, pp. 170 - 171, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000852585700254&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pudipeddi A; Fung C; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An Y; Begun J; Connor S; Chetwood J; Paramsothy S; Leong R, 2022, 'IDDF2022-ABS-0162 Histological remission using a nancy index of 0 is associated with longer relapse-free survival than histological activity in patients with ulcerative colitis in clinical and endoscopic remission', BMJ, pp. a149.2 - a1a149, presented at Clinical Gastroenterology, http://dx.doi.org/10.1136/gutjnl-2022-iddf.207

Haifer C; Saikal A; Paramsothy S; Borody TJ; Ghaly S; Kaakoush NO; Leong RW, 2021, 'LYOPHILIZED ORALLY ADMINISTERED FECAL MICROBIOTA TRANSPLANTATION IN THE MANAGEMENT OF ULCERATIVE COLITIS (LOTUS STUDY) - RESULTS FROM THE INDUCTION PHASE OF A RANDOMIZED CONTROLLED TRIAL', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, ELECTR NETWORK, Vol. 160, pp. S135 - S135, presented at Society-for-Surgery-of-the-Alimentary-Tract Annual Meeting at Digestive Disease Week (DDW), ELECTR NETWORK, 21 May 2021 - 23 May 2021, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000649085000323&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Haifer C; Saikal A; Paramsothy S; Borody TJ; Ghaly S; Kaakoush NO; Leong RW, 2020, 'Lyophilised Oral Faecal Microbiota Transplantation in the Management of Ulcerative Colitis (LOTUS Study): Results from the induction phase of a randomized controlled trial', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 116 - 117, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200169&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Haifer C; Lucas RM; Clarke MW; Lawrance I; Hart PH; Center JR; Eisman JA; Ghaly S, 2018, 'Vitamin D deficiency in Crohn's disease', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 12, pp. S152 - S153, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000427318900247&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Preprints

Haifer C; Paramosthy S; Kaakoush NO; Saikal A; Ghaly S; Luu LD; Borody TJ; Leong RW, 2021, Lyophilised Oral Faecal Microbiota Transplantation in Ulcerative Colitis - a Randomised Placebo-Controlled Trial, http://dx.doi.org/10.2139/ssrn.3931753

Chen-Liaw A; Aggarwala V; Mogno I; Haifer C; Li Z; Eggers J; Helmus D; Hart A; Wehkamp J; Lamousé-Smith ES; Kerby RL; Rey FE; Colombel JF; Kamm MA; Borody TJ; Grinspan A; Paramsothy S; Kaakoush NO; Dubinsky MC; Faith JJ, Gut microbiota bacterial strain richness is species specific and limits therapeutic engraftment, http://dx.doi.org/10.1101/2022.11.01.514782

Back to profile page